Rinvoq
Rinvoq 30 Tablets Extended Release 24 Hour
What is Rinvoq?
Rinvoq (upadacitinib) is a prescription medication manufactured by AbbVie Inc. It is a Janus kinase (JAK) inhibitor used for treating moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in adults when one or more treatments have failed to provide sufficient relief. Rinvoq works by inhibiting specific enzymes involved in the inflammatory process, thereby reducing inflammation and other symptoms associated with these conditions.Side Effects
- Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
- Chest pain that may spread, trouble breathing, coughing up blood, unusual sweating, fainting
- Dark urine or pale stools, nausea, vomiting, loss of appetite, yellow skin or eyes
Warnings
- It is not safe to take this medicine during pregnancy. It could harm an unborn baby. Tell your doctor right away if you become pregnant. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before starting this medicine. Use an effective form of birth control during treatment with this medicine and for at least 4 weeks after the last dose.
- Do not breastfeed during treatment with this medicine and for at least 6 days after the last dose.
- Tell your doctor if you have kidney disease, liver disease (including hepatitis B or C), blood problems, cancer or a history of cancer, diabetes, lung disease, HIV, stomach or bowel problem (including diverticulitis), or a history of tuberculosis. Tell your doctor if you have a current infection or an infection that keeps coming back, or if you are a current or past smoker.
- This medicine may cause the following problems:Increased risk of serious infections (bacterial, fungal, viral), including herpes infection or shinglesIncreased risk of cancer (including lymphoma, lung cancer, skin cancer)Increased risk of serious heart or blood vessel disease (including heart attack, stroke)Increased risk of blood clots (including arterial thrombosis, deep vein thrombosis, pulmonary embolism), especially in patients with rheumatoid arthritis who are 50 years of age and older and with a heart or blood vessel diseaseStomach or bowel perforation (tear or hole)High cholesterol in the blood
- You will need to have a skin test for tuberculosis (TB) before you start this medicine. Tell your doctor if you or anyone in your home has ever had a positive TB skin test or been exposed to TB.
Prescription savings · · ·
- Allergic reaction: Itching or hives, swelling in your face or hands, swelling or tingling in your mouth or throat, chest tightness, trouble breathing
- Chest pain that may spread, trouble breathing, coughing up blood, unusual sweating, fainting
- Dark urine or pale stools, nausea, vomiting, loss of appetite, yellow skin or eyes
- Fever, chills, cough, runny or stuffy nose, sore throat, night sweats, body aches
- Numbness or weakness in your arm or leg, or on one side of your body
- Pain, redness, swelling, or tenderness in the arms or legs
- Skin or mole changes, sores that do not heal
- Stomach pain, cramping, bloody stools
- Unusual bleeding, bruising, or weakness
- Sores, reddish patch or irritated area, shiny bump, or pink growth on the skin
- Sudden or severe headache, problems with vision, speech, or walking
- It is not safe to take this medicine during pregnancy. It could harm an unborn baby. Tell your doctor right away if you become pregnant. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before starting this medicine. Use an effective form of birth control during treatment with this medicine and for at least 4 weeks after the last dose.
- Do not breastfeed during treatment with this medicine and for at least 6 days after the last dose.
- Tell your doctor if you have kidney disease, liver disease (including hepatitis B or C), blood problems, cancer or a history of cancer, diabetes, lung disease, HIV, stomach or bowel problem (including diverticulitis), or a history of tuberculosis. Tell your doctor if you have a current infection or an infection that keeps coming back, or if you are a current or past smoker.
- This medicine may cause the following problems:Increased risk of serious infections (bacterial, fungal, viral), including herpes infection or shinglesIncreased risk of cancer (including lymphoma, lung cancer, skin cancer)Increased risk of serious heart or blood vessel disease (including heart attack, stroke)Increased risk of blood clots (including arterial thrombosis, deep vein thrombosis, pulmonary embolism), especially in patients with rheumatoid arthritis who are 50 years of age and older and with a heart or blood vessel diseaseStomach or bowel perforation (tear or hole)High cholesterol in the blood
- You will need to have a skin test for tuberculosis (TB) before you start this medicine. Tell your doctor if you or anyone in your home has ever had a positive TB skin test or been exposed to TB.
- This medicine may make you bleed, bruise, or get infections more easily. Take precautions to prevent illness and injury. Wash your hands often.
- This medicine may make your skin more sensitive to sunlight. Wear sunscreen. Do not use sunlamps or tanning beds.
- Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments.
- Keep all medicine out of the reach of children. Never share your medicine with anyone.
Rinvoq Coupons & Prices
Rinvoq 30 Tablets Extended Release 24 Hour
What is Rinvoq ?
Rinvoq (upadacitinib) is a prescription medication manufactured by AbbVie Inc. It is a Janus kinase (JAK) inhibitor used for treating moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in adults when one or more treatments have failed to provide sufficient relief. Rinvoq works by inhibiting specific enzymes involved in the inflammatory process, thereby reducing inflammation and other symptoms associated with these conditions.